Publication: Hysteroscopic myomectomy for submucosal Myoma: Literature review
Issued Date
2021-01-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-85113287948
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.104, No.8 (2021), 1393-1399
Suggested Citation
Siriluk Tantanavipas Hysteroscopic myomectomy for submucosal Myoma: Literature review. Journal of the Medical Association of Thailand. Vol.104, No.8 (2021), 1393-1399. doi:10.35755/jmedassocthai.2021.08.12807 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78648
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Hysteroscopic myomectomy for submucosal Myoma: Literature review
Author(s)
Other Contributor(s)
Abstract
Uterine myomas are usually asymptomatic, although, most women with submucous myoma have severe symptom including abnormal uterine bleeding and infertility. Hysteroscopic myomectomy is a minimally invasive surgery and is a key benefit to patient care. Patient with submucous myoma no longer requires hysterotomy. Hysteroscopic myomectomy became the gold standard treatment in women who desire to preserve fertility. Complete removal of myoma in one-step procedure should be considered. Pre-operative optimization with cervical ripening agents including osmotic dilators such as laminaria tents and prostaglandin such as misoprostol and dinoprostone is important and decrease the risk of cervical trauma as well as uterine perforation. During the procedure, low viscosity isotonic conductive media such as normal saline are recommended to use with bipolar resectoscope and mechanical morcellator, and fluid deficit should be closely monitored at a minimum of 10-minute intervals. Resectoscope is usually used with slicing technique for resection of myoma. Morcellator can be used as it is easy to use, reduces risk of perforation, and reduces non-electrical currents. However, there is a limited utility in type 2 myoma. In addition, hyaluronic acid and polyethylene oxidesodium carboxymethylcellulose gel may reduce intrauterine adhesion after hysteroscopic myomectomy.